| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 08/23/2001 | US20010016319 Cloning of a novel G-protein coupled 7TM Receptor |
| 08/23/2001 | US20010016218 Method for production of arachidonic acid |
| 08/23/2001 | US20010016199 Alphavirus RNA replicon systems |
| 08/23/2001 | US20010016197 Cultivating a fungi of the basidiomycetes in a submerged culture on nutrient media, isolating the biomass of edible mushrooms from the culture broth, and drying at a range of 40-45 degrees celsius |
| 08/23/2001 | US20010016191 Viewing informatoin, selecting a site for, and preparing a molecule of an alteration on a granulocyte colony-stimulating factor (g-csf) three dimensional molecule, and testing for desired characteristics; retain internal core helices |
| 08/23/2001 | CA2400087A1 Altered recombinases for genome modification |
| 08/23/2001 | CA2398861A1 Gene disruption methodologies for drug target discovery |
| 08/22/2001 | EP1126024A1 Novel thermostable collagen-digesting enzyme, novel microorganism producing the enzyme and process for producing the enzyme |
| 08/22/2001 | EP1125947A1 HUMAN H37 PROTEINS AND cDNAS ENCODING THE SAME |
| 08/22/2001 | EP1125498A2 Spore germination inhibitor and food using the same |
| 08/22/2001 | EP1125130A1 Detection of acid-resistant micro-organisms in a stool |
| 08/22/2001 | EP1124987A2 Methods for screening protease variants for use in detergent compositions |
| 08/22/2001 | EP1124984A1 Host cells expressing recombinant human erythropoietin |
| 08/22/2001 | EP1124983A1 Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids |
| 08/22/2001 | EP1124978A1 AN UNUSUAL RETROTRANSPOSON FROM THE YEAST $i(CANDIDA ALBICANS) |
| 08/22/2001 | EP1124976A1 Improved aav vector production |
| 08/22/2001 | EP1124972A1 VECTOR FOR THE TRANSFORMATION OF $i(PHAFFIA RHODOZYMA) AND PROCESS OF TRANSFORMATION THEREBY |
| 08/22/2001 | EP1124969A2 Recombinant oleandolide polyketide synthase |
| 08/22/2001 | EP1124968A2 Library of novel "unnatural" natural products |
| 08/22/2001 | EP1124966A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 08/22/2001 | EP1124965A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/22/2001 | EP1124964A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/22/2001 | EP1124962A1 Maize kin17 orthologues and uses thereof |
| 08/22/2001 | EP1124947A2 Construction of production strains for producing substituted phenols by specifically inactivating genes of the eugenol and ferulic acid catabolism |
| 08/22/2001 | EP1124946A1 Glycosylated proteins having reduced allergenicity |
| 08/22/2001 | EP1124944A2 Mutant luciferase having increased thermostability |
| 08/22/2001 | EP1124943A1 Nucleic acids encoding taxus geranylgeranyl diphosphate synthase, and methods of use |
| 08/22/2001 | EP1124856A1 Conformation-specific anti-von willebrand factor antibodies |
| 08/22/2001 | EP1124850A1 12 human secreted proteins |
| 08/22/2001 | EP1124846A2 Nucleotide and protein sequences of nogo genes and methods based thereon |
| 08/22/2001 | EP1124813A1 Microbial transformation product |
| 08/22/2001 | EP1124568A1 Polyspecific binding molecules and uses thereof |
| 08/22/2001 | EP1124560A1 Use of antifungal agents for treating scleroses |
| 08/22/2001 | EP0904354A4 NOVEL PLANT STEROID 5alpha REDUCTASE, DET2 |
| 08/22/2001 | EP0809516B1 Medicinal combination useful for in vivo exogenic transfection and expression |
| 08/22/2001 | EP0795022B1 Municipal solid waste processing facility and commercial lactic acid production process |
| 08/22/2001 | EP0764204B1 HUMAN OXALYL-CoA DECARBOXYLASE |
| 08/22/2001 | EP0725794B1 Human monocyte chemoattractant protein-1 (mcp-1) derivatives |
| 08/22/2001 | EP0673255B1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 08/22/2001 | EP0616645B1 Prohormone convertase transformed cells |
| 08/22/2001 | EP0550645B1 Surface expression libraries of heteromeric receptors |
| 08/22/2001 | EP0309565B2 Subtilisin analogs |
| 08/22/2001 | CN1309720A Virulence-associated nucleic acid sequences and uses thereof |
| 08/22/2001 | CN1309718A Improved microbial strains producing sphingoid bases |
| 08/22/2001 | CN1309716A Expression system contg. chimeric promoters with binding sites for recombinant transcription factors |
| 08/22/2001 | CN1309712A Method of making proteins in transformed yeast cells |
| 08/22/2001 | CN1309711A Methods for producing heterologous polypeptides in trichothecene-deficient filamentous fungal nutant cells |
| 08/22/2001 | CN1309710A Genomic sequences upstream of coding region of IFN-alpha 2 gene for protein production and delivery |
| 08/22/2001 | CN1309708A Postweaning multisystemic wasting syndrome virus from pigs |
| 08/22/2001 | CN1309707A BASB029 polynucleotide(s) and polypeptides from i(neisseria meningitidis) |
| 08/22/2001 | CN1309706A Compound from moraxella catarrhalis |
| 08/22/2001 | CN1309703A Mutants of mycobacterium species and use of same for screening for antibiotics vectors |
| 08/22/2001 | CN1309700A Glucoamylase variants |
| 08/22/2001 | CN1309665A Antibodies capable of detecting beer spoilage lactic acid bacteria and detecting method using same, and reagent kit with same |
| 08/22/2001 | CN1309664A Anti hepatitis C virus antibody and uses thereof |
| 08/22/2001 | CN1309566A Nocathiacin antibiotics |
| 08/22/2001 | CN1309184A Operation of enzymatic vitality of protoporphyrin primary oxidase in eukaryote |
| 08/22/2001 | CN1069895C Legionella specific antibiotic, microorganism producing antibiotic and process for producing same |
| 08/21/2001 | US6277977 cDNA clone HAPOI67 that encodes a human 7-transmembrane receptor |
| 08/21/2001 | US6277972 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells |
| 08/21/2001 | US6277971 Dna which codes for nap protein of defined amino acid sequence; diagnosis and treatment of acquired immune deficiency syndrome (aids) |
| 08/21/2001 | US6277965 Amino acid sequence of cysteinyl trna (transfer ribonucleic acid) synthetase from chlamydia; bactericides; bacteriostats; enzyme inhibitors; drug screening; diagnosis; vaccines |
| 08/21/2001 | US6277964 Anti-PAH monoclonal antibodies and cell lines producing the same |
| 08/21/2001 | US6277963 Antibodies directed toward extracellular signal-related kinases |
| 08/21/2001 | US6277962 Receptor on the surface of activated t-cells: act-4 |
| 08/21/2001 | US6277960 Amino acid sequence of g protein coupled receptor; treatment of eating disorders, asthma, parkinson's disease, cardiovascular and nervous system disorders, huntington's disease, tourett's syndrome, and others; diagnosis |
| 08/21/2001 | US6277822 Family of peptides known as xenoxins |
| 08/21/2001 | US6277631 Recombinant yeast (schizosaccharomyces pombe or saccharomyces cerevisiae) expression vectors |
| 08/21/2001 | US6277620 Polypeptide for the prevention of bacterial infection; bactericides; for vaccine development |
| 08/21/2001 | US6277618 Enzymatic protein; for use in diagnosis of blood disorders; for use in detection of modulators of blood coagulation |
| 08/21/2001 | US6277615 (1→3, 1→4)—β-glucanase of enhanced stability |
| 08/21/2001 | US6277602 By adding bacteria selected from xanthomonas campestris, x. phaseoli, x. pisi, x. oryzae, x. cucurbitae, x. citri and stenotrophomonas maltophilia to a sugar and 1-menthol reaction medium; high yields |
| 08/21/2001 | US6277599 Monoclonal antiboby for the preferential killing of tumors; for diagnosis of cancer; for the treatment of cancer |
| 08/21/2001 | US6277594 Neurogenesis inducing gene |
| 08/21/2001 | US6277590 Genetically engineered aggregates for generating preferential heterologous proteins |
| 08/21/2001 | US6277586 Used for detecting the presence of autoantibodies to glutamic acid decarboxylaes (gad) in a biological sample |
| 08/21/2001 | US6277577 Hybridization probes derived from the spacer region between the 16s and 23s rRNA genes for the detection of non-viral microorganisms |
| 08/21/2001 | US6277564 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 08/21/2001 | CA2121889C Production and use of multimeric hemoglobins |
| 08/21/2001 | CA2090969C Production of insulin-like growth factor-1 in methylotrophic yeast cells |
| 08/21/2001 | CA2059167C Expression of human serum albumin in pichia pastoris |
| 08/21/2001 | CA2012955C Antitumor substance be-13793c |
| 08/16/2001 | WO2001059163A2 Method for detecting and quantifying adenovirus |
| 08/16/2001 | WO2001059145A1 Regulated expression of plac in staphylococcus aureus |
| 08/16/2001 | WO2001059126A2 Gene cluster encoding a nystatin polyketide synthase and its manipulation and utility |
| 08/16/2001 | WO2001059089A2 Improved galactosylation of recombinant glycoproteins |
| 08/16/2001 | WO2001059086A2 Methods and constructs for agrobacterium-mediated plant transformation |
| 08/16/2001 | WO2001058944A1 Sodium-independent small neutral amino acid transporters transporting l- and d-amino acids and genes thereof |
| 08/16/2001 | WO2001011024A3 Bryostatins, bryopyrans and polyketides: compositions and methods |
| 08/16/2001 | WO2000006739A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/16/2001 | US20010014672 High molecular weight major outer membrane protein of moraxella |
| 08/16/2001 | US20010014476 Region which allows its replication comprises an origin of replication derived from a plasmid or a bacteriophage and whose functionality in the host cell requires the presence of at least one specific protein foreign to host cell |
| 08/16/2001 | US20010014474 Preparing hybridoma cell line which produces antibody which specifically recognizes and binds to cell surface antigen associated with a neoplastic human cell; diagnosis, therapy |
| 08/16/2001 | US20010014325 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 08/16/2001 | US20010014324 Agent for inducing resistance against phytopathogenic microorganisms in plants wherein the agent is an extract of biomass derived from biotechnological fermentation processes, from non-plant-pathogenic microorganisms |
| 08/16/2001 | EP1123979A1 Process for producing coenzyme q 10? |
| 08/16/2001 | EP1123409A2 Method of producing gamma-decalactone |
| 08/16/2001 | EP1123391A2 Methods for improving the function of heterologous g protein-coupled receptors |
| 08/16/2001 | EP1123388A1 Transgenic c. elegans as a model organism for research into alzheimer's disease |
| 08/16/2001 | EP1123387A2 Mn gene and protein |